The Manufacturers Life Insurance Company Sells 11,914 Shares of Synopsys, Inc. $SNPS

The Manufacturers Life Insurance Company decreased its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 8.1% during the 1st quarter, Holdings Channel reports. The fund owned 135,813 shares of the semiconductor company’s stock after selling 11,914 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Synopsys were worth $53,835,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of SNPS. Norges Bank acquired a new stake in Synopsys in the fourth quarter worth $730,197,000. State Street Corp boosted its position in shares of Synopsys by 20.6% during the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock worth $4,322,273,000 after purchasing an additional 1,493,912 shares in the last quarter. Farallon Capital Management LLC acquired a new position in shares of Synopsys in the 4th quarter valued at $469,344,000. Primecap Management Co. CA grew its holdings in shares of Synopsys by 743.6% in the 4th quarter. Primecap Management Co. CA now owns 734,800 shares of the semiconductor company’s stock valued at $345,150,000 after buying an additional 647,700 shares during the period. Finally, Employees Provident Fund Board bought a new stake in shares of Synopsys in the 4th quarter valued at $302,661,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on SNPS. Wells Fargo & Company raised their price objective on Synopsys from $505.00 to $535.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 28th. Piper Sandler upgraded Synopsys from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $450.00 to $550.00 in a report on Tuesday, June 23rd. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a research report on Thursday, May 28th. Rosenblatt Securities lifted their price objective on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a report on Tuesday, May 26th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a research report on Monday, June 8th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $570.06.

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by company insiders.

Synopsys News Summary

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Expanded Nvidia partnership supports AI growth. Nvidia is adding Synopsys to its Agent Toolkit ecosystem, helping automate chip and system design. The relationship could increase demand for Synopsys’ electronic design automation (EDA) software as semiconductor companies adopt agentic AI. Agentic AI Is Coming to Chip Design. Here Is Why Synopsys Stock Could Be the Biggest Beneficiary
• Positive Sentiment: AI alliances may strengthen Synopsys’ strategic position. Partnerships involving Nvidia, AMD, Microsoft and Intel are aimed at automating chip-design bottlenecks, potentially improving productivity for customers and reinforcing Synopsys’ central role in the semiconductor ecosystem. Synopsys Just Solved a Bottleneck You Didn’t Even Know Existed
• Positive Sentiment: Intel’s next-generation 14A process provides another validation point. Synopsys’ tools are already supporting Intel’s 14A chip-development efforts, highlighting the importance of its software in advanced semiconductor manufacturing. Intel’s 14A chips aren’t built yet: Synopsys is already there
• Neutral Sentiment: Recent results remain solid but acquisition-driven. Quarterly revenue rose 41.9% year over year to $2.28 billion and EPS exceeded expectations, largely reflecting the Ansys acquisition. Investors may be looking for stronger organic growth to support Synopsys’ premium valuation. Synopsys: How Agentic AI And Ansys Drive Long-Term Growth
• Negative Sentiment: The immediate decline appears tied more to market and valuation pressure than a new fundamental setback. Reports noted that Synopsys underperformed the broader market during the latest session, while its elevated earnings multiple and recent underperformance likely encouraged caution and profit-taking. No new earnings warning was cited. Here’s Why Synopsys Fell More Than Broader Market

Synopsys Price Performance

Shares of NASDAQ SNPS opened at $373.69 on Thursday. The company has a fifty day moving average price of $449.23 and a 200 day moving average price of $452.19. The firm has a market cap of $71.55 billion, a PE ratio of 86.50, a PEG ratio of 2.25 and a beta of 1.22. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 1-year low of $366.00 and a 1-year high of $651.73.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. The firm had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company’s revenue for the quarter was up 41.9% on a year-over-year basis. During the same quarter last year, the business posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Research analysts predict that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.